CC
AUPH icon

Centiva Capital’s Aurinia Pharmaceuticals AUPH Stock Holding History

Centiva Capital’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-316
Closed -$3.06K – 1714
2023
Q2 		$3.06K Buy
+316
New +$3.28K ﹤0.01% 1572
2021
Q2 		– Sell
-10,123
Closed -$131K – 1375
2021
Q1 		$131K Buy
+10,123
New +$147K 0.01% 1040

Other funds holding AUPH

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Centiva Capital's AUPH Position: Q3 2023 in Review

Centiva Capital sold out of Aurinia Pharmaceuticals (AUPH) in Q3 2023, closing a stake of 316 shares — an estimated $3.06K sold.

Centiva Capital first reported a position in AUPH in Q1 2021 and held it in 2 quarters. The position peaked at $131K in Q1 2021. 198 funds tracked by Wall St. Rank hold AUPH as of Q3 2023.

  • Centiva Capital reported no remaining Aurinia Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Centiva Capital sold 316 Aurinia Pharmaceuticals shares in Q3 2023, an estimated $3.06K.
  • Centiva Capital first reported a position in Aurinia Pharmaceuticals in Q1 2021 and held it in 2 quarters.
  • Centiva Capital's Aurinia Pharmaceuticals position peaked at $131K in Q1 2021.
  • 198 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2023.

Based on Centiva Capital's 13F filing for Q3 2023, filed 14 Nov 2023.